Annexon Inc
ANNX
NASDAQ
Biotechnology
$5.29
USD
+0.03 (+0.57%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $856.08M
Volume 3.0M
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
OLMA | Olema Pharmaceuticals Inc | $919.60M | - | - | - | |
DSGN | Design Therapeutics Inc | $900.55M | - | - | - | |
CADL | Candel Therapeutics Inc | $864.59M | - | - | - | |
ANNX | Annexon Inc | $856.08M | - | - | - | |
CLYM | Climb Bio Inc | $846.04M | - | - | - | |
AURA | Aura Biosciences Inc | $793.34M | - | - | - | |
IMMX | Immix Biopharma Inc | $781.21M | - | - | - | |
RIGL | Rigel Pharmaceuticals Inc | $780.54M | 2.42 | +3.3% | - | |
FTH | Faeth Therapeutics, Inc | $737.74M | - | - | - |
Top Peer by Growth
Rigel Pharmaceuticals Inc
+3.3% YoY Revenue
Lowest P/E Ratio
Rigel Pharmaceuticals Inc
2.42x P/E
Best 1-Year Return
Climb Bio Inc
+793.8% Return